This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

This study is currently recruiting participants.
See Contacts and Locations
Verified July 2017 by David Fiellin, Yale University
Sponsor:
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
VA Office of Research and Development
Information provided by (Responsible Party):
David Fiellin, Yale University
ClinicalTrials.gov Identifier:
NCT01410123
First received: July 28, 2011
Last updated: July 18, 2017
Last verified: July 2017
History of Changes
July 28, 2011
July 18, 2017
January 2013
January 2018   (Final data collection date for primary outcome measure)
  • At risk drinking: Drinks per week [ Time Frame: 6 months ]
  • Alcohol abuse or dependence: Drinks per week [ Time Frame: 6 months ]
  • Moderate Alcohol + Liver Disease group: Abstinence. [ Time Frame: 6 months ]
Same as current
Complete list of historical versions of study NCT01410123 on ClinicalTrials.gov Archive Site
Change in biological markers as measured by the VACS index. [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
 
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
The study is a series of 3 linked randomized clinical trials of 6 month duration, with a total of 12 month follow-up, to evaluate the effect of Integrated Stepped Care on drinking outcomes and HIV biologic markers (including VACS index) in HIV-infected patients with unhealthy alcohol use.
Unhealthy alcohol use threatens the health benefits seen with antiretroviral therapy (ART) for HIV-infected (HIV+) patients. Although research has demonstrated the efficacy of brief interventions, motivational counseling, and medications to treat unhealthy alcohol use in HIV uninfected patients, there is limited research or use of these treatments in HIV+ patients. We have demonstrated that integrated treatment of addiction in HIV clinics is feasible. Stepped care algorithms can facilitate the evaluation of varying intensities of treatments for unhealthy alcohol use. The proposed study will compare onsite Integrated Stepped Care treatment (ISC) to treatment as usual (TAU) in three, linked, 6-month randomized clinical trials in 642 HIV+ patients with unhealthy alcohol use. Screened patients are randomized to ISC or TAU after determining that they meet criteria for either 1) at-risk drinking, 2) alcohol abuse or dependence or 3) moderate alcohol consumption in the presence of liver disease. ISC and TAU are tailored to the drinking category. ISC for at-risk drinkers and those with Moderate Alcohol use and Liver Disease begins with a brief intervention and is stepped up to Motivational Enhancement Therapy (MET) in those who meet predefined failure criteria. ISC for abuse or dependence begins with addiction physician management (APM) including alcohol pharmacotherapy if not contraindicated. APM is stepped up to include MET if predefined failure criteria are met. The study will test the hypothesis that ISC leads to decreased alcohol consumption and improved HIV biomarkers. Data analyses will be conducted on the intention to treat sample.
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Liver Diseases, Alcoholic
  • Alcoholism
  • HIV
  • Hepatitis C
  • Other: Integrated Stepped Care (ISC)

    1. At risk drinking:

      Step 1: Brief negotiated interview (BNI) + booster; Step 2: Motivational Enhancement Therapy; Step 3: Addiction Physician Management + Alcohol pharmacotherapy

    2. Alcohol abuse/dependence:

      Step 1: Addiction Physician Management + Alcohol Pharmacotherapy; Step 2: Motivational Enhancement Therapy; Step 3: Detoxification and aftercare

    3. Moderate Alcohol + Liver Disease:

    Step 1: Brief Negotiated Interview (BNI)+ booster; Step 2: Motivational Enhancement Therapy; Step 3: Addiction physician management + alcohol pharmacotherapy.

  • Other: Treatment as Usual
    The TAU arm will receive a handout with alcohol information embedded within general health-related information (exercise, smoking cessation, and flu vaccination) and standard care as provided by their treating physician. All patients will have access to a NIAAA informational website.
  • Treatment as Usual (TAU)
    Intervention: Other: Treatment as Usual
  • Integrated Stepped Care (ISC)
    Intervention: Other: Integrated Stepped Care (ISC)
Edelman EJ, Hansen NB, Cutter CJ, Danton C, Fiellin LE, O'Connor PG, Williams EC, Maisto SA, Bryant KJ, Fiellin DA. Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics. Addict Sci Clin Pract. 2016 Jan 13;11(1):1. doi: 10.1186/s13722-015-0048-z.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
642
January 2018
January 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Be HIV-infected and receiving HIV care at one of the participating medical centers.

  2. Meet one of the following criteria for unhealthy alcohol use:

    • At-risk Drinking Study- greater than 14 drinks per week or greater than 4 drinks per occasion in men and greater than 7 drinks per week or greater than 3 drinks per occasion in women and those over 65.
    • Alcohol Abuse or Dependence Study - Meet DSM-IV TR criteria for alcohol abuse or dependence, not in remission.
    • Moderate Alcohol + Liver Disease Study - Report alcohol consumption in the past month, are HCV co-infected, confirmed by HCV viral load or have liver fibrosis - Fib-4 (>1.45). Do not meet criteria for at-risk drinking, alcohol abuse or dependence.
  3. Be able to understand English and provide informed consent.

Exclusion Criteria:

  1. Be acutely suicidal, or with a psychiatric condition that affects the ability to provide informed consent or participate in counseling interventions (e.g. psychotic, dementia, delusional).
  2. Be currently enrolled in formal treatment for alcohol (excluding self-help, e.g. Alcoholics Anonymous)
  3. Have medical conditions that would preclude completing or be of harm during the course of the study.
  4. Pregnant or nursing women or women who do not agree to use a reliable form of birth control.
Sexes Eligible for Study: All
21 Years and older   (Adult, Senior)
No
Contact: David A Fiellin, MD 203-737-3347 david.fiellin@yale.edu
Contact: Evangelia H Louizos, BS 203-737-3347 evangelia.louizos@yale.edu
United States
 
 
NCT01410123
HIC1105008544
U01AA020795 ( U.S. NIH Grant/Contract )
Yes
Not Provided
Not Provided
David Fiellin, Yale University
Yale University
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • VA Office of Research and Development
Principal Investigator: David Fiellin, MD Yale University
Study Director: Jennifer Edelman, M.D., MHS Yale University
Yale University
July 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP